CORZ
The table below shows Core Scientific, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.01B | $453.44M | $581.35M | $697.94M | $253.02M | $96.12M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | $1.02M | $6.24M | $4.68M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.45B |
| $1.06B |
| $1.00B |
| $833.18M |
| $277.86M |
| $117.86M |
| Property, plant & equipment | $1.34B | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.07B | $2.30B | $1.98B | $1.63B | $921.85M | $761.46M |
| Accounts payable | $218.86M | $212.18M | $215.06M | $6.33M | $6.50M | $8.49M |
| Total current liabilities | $2.66B | $669.86M | $562.72M | $195.51M | $76.51M | $74.82M |
| Long-term debt | $1.06B | - | - | - | - | - |
| Total liabilities | $4.38B | $3.42B | $3.04B | $1.81B | $1.65B | $1.85B |
| Retained earnings | -$4.49B | -$4.24B | -$4.09B | -$3.15B | -$3.47B | -$3.01B |
| Total equity | -$1.31B | -$1.13B | -$1.19B | -$181.51M | -$729.39M | -$1.08B |